AngioChem to Present at the American Society of Human Genetics 2013 Annual Meeting
Published: Oct 17, 2013
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced that an abstract on its Angiopep-2 (An2) conjugate technology has been selected for presentation at the American Society of Human Genetics (ASHG) 2013 Annual Meeting being held October 22-26, 2013 in Boston, Massachusetts.
Help employers find you! Check out all the jobs and post your resume.